Matthew Willadsen

The paper evaluates a laparoscopic fluorescence imaging platform to quantify light-triggered drug release in cancer models, showing strong correlation with standard measurements and potential for guided treatment.

This paper develops a laparoscopic SFDI system to monitor porphyrin phospholipid photobleaching and doxorubicin release in an ovarian cancer model, demonstrating its potential for real-time intraoperative monitoring of chemophototherapy.